Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
about
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseThe dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GHIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodiesAPOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityAPOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitisTurning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)HIV-1 Vif, APOBEC, and intrinsic immunityHuman APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityStructural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assemblyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationAll APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GHuman immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integrationMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allEvolution of foamy viruses: the most ancient of all retrovirusesThe APOBEC3 family of retroelement restriction factorsHIV-1 reverse transcriptionSuppression of APOBEC3-mediated restriction of HIV-1 by VifStructural Insights into HIV-1 Vif-APOBEC3F InteractionCross-Species Virus Transmission and the Emergence of New Epidemic DiseasesRNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapyCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsInteraction of APOBEC3A with DNA assessed by atomic force microscopyAPOBEC3G: an intracellular centurionHypermutation of an ancient human retrovirus by APOBEC3GInability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.The restriction of zoonotic PERV transmission by human APOBEC3G.T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.APOBEC3G inhibits elongation of HIV-1 reverse transcripts.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins
P2860
Q21131577-E052F91A-2E83-4956-91CC-3822D5DEB90BQ21245195-977DC56D-6CF7-4F00-B9D8-FC504553FB37Q24297395-8A10F310-E1AD-4D13-9348-83EA8605813AQ24310242-E5D74603-2085-4387-98A8-84E850E430B4Q24317568-88203E92-6061-48A3-84C8-41977CA97CCCQ24565021-73EC81B7-E2B2-40E1-8E90-374F6C332223Q24619114-5688A35E-CBAE-4A14-BECF-124A47C4ABFDQ24625056-80F00E7C-C496-428A-B149-0DABCFDCCE09Q24634922-5C1125FC-4EE3-43A8-95EA-F14E4E21D36EQ24645606-A656C591-F926-459D-90B6-B9B9C34B8DF5Q24647833-40D120D0-8771-4B9E-BFB9-60E064D21E9BQ24655541-EA3BBFAE-66F8-4C21-9231-59743A4094F5Q24656551-0EF1DAB8-10F1-44DB-94D2-E36458B05F34Q24658171-A931FFCE-4B8B-41D6-A37D-578832BFF3E2Q24672209-1E6A6533-2177-4487-99B3-F8C1B74DCFECQ24675735-9D05D9BE-B187-4DE6-B6E8-09C713BCC933Q24681427-2374AA9D-CB26-445D-92DF-6F736F2051A6Q24684279-9D5B1000-307A-454E-B8B3-F7941D11B55AQ26823568-39A847D3-42D1-4A39-A7ED-29071F2C1416Q26852372-15E6D03D-9E4C-4094-820E-02A3E1970C8CQ26862780-423B7739-FD45-44B7-96F0-D04BC5878DDCQ27023387-EEB5F3D4-8620-4536-A2D9-FD10EA084D5AQ27025150-46CD8EEA-B2AD-4C50-BE96-EA101BE454DDQ27321018-8F5655F7-D940-4B6D-AA30-1CD5225F1290Q27486915-A4C34C51-7398-4A06-BC98-92921FD95931Q28474904-D1EC5F02-A792-4300-8965-E5895D1C8D50Q28480578-CC697E6F-2670-4C01-8CFB-27E4DBE78D3FQ28482052-93509DBE-E0FE-400A-8EE8-D109656B9F52Q28539478-41CA0293-3FC5-4D94-979A-C57E391E5DBAQ28754989-C15450D5-A92D-474C-BD67-CBD33FDBA463Q28757351-D80C1DBB-F79D-4977-94F6-D70A2D7C2353Q30439541-A42DC850-7091-4FC6-BC2B-E9D1771A77FDQ30483676-2169EA59-3FD3-4546-9130-39687E8105AAQ33289183-C41BC4D9-D034-4D47-860B-6D7EDE035F11Q33298609-872EF186-A0F6-46A1-9A1A-DE81F6F6E37EQ33300132-8B35415F-0C69-4AC7-99C1-BF5E8105BCDFQ33328499-2FBBBE96-C5A6-4793-849E-44DACDEA64DBQ33349452-9D94F6A3-4F95-497E-AAB3-265181A8A62EQ33389841-32F1FD00-8E58-4AFE-9192-1E385675AC9BQ33393637-620E9DA7-C38B-4C7E-BEE2-7DBFF420972B
P2860
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
@en
type
label
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
@en
prefLabel
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
@en
P2860
P356
P1433
P1476
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
@en
P2093
Kate N Bishop
Rebecca K Holmes
P2860
P304
P356
10.1128/JVI.00839-06
P407
P577
2006-09-01T00:00:00Z